Wolfs TF - Search Results

1

Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1.

Zwart G, Wolfs TF, Valk M, Van der Hoek L, Kuiken CL, Goudsmit J. Zwart G, et al. Among authors: wolfs tf. AIDS Res Hum Retroviruses. 1992 Nov;8(11):1897-908. doi: 10.1089/aid.1992.8.1897. AIDS Res Hum Retroviruses. 1992. PMID: 1489578

2

Assessment of HIV-1 antigenic diversification using serum as sample source.

Goudsmit J, Zwart G, Wolfs T. Goudsmit J, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1473. doi: 10.1089/aid.1992.8.1473. AIDS Res Hum Retroviruses. 1992. PMID: 1466985 No abstract available.

3

HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.

Wolfs TF, Zwart G, Bakker M, Goudsmit J. Wolfs TF, et al. Virology. 1992 Jul;189(1):103-10. doi: 10.1016/0042-6822(92)90685-i. Virology. 1992. PMID: 1376536

4

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution.

Wolfs TF, Zwart G, Bakker M, Valk M, Kuiken CL, Goudsmit J. Wolfs TF, et al. Virology. 1991 Nov;185(1):195-205. doi: 10.1016/0042-6822(91)90767-6. Virology. 1991. PMID: 1656585

5

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

Zwart G, Langedijk H, van der Hoek L, de Jong JJ, Wolfs TF, Ramautarsing C, Bakker M, de Ronde A, Goudsmit J. Zwart G, et al. Among authors: wolfs tf. Virology. 1991 Apr;181(2):481-9. doi: 10.1016/0042-6822(91)90880-k. Virology. 1991. PMID: 2014634

6

Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection.

Wolfs TF, Geelen JL, Schellekens H, Barin F, Dekker JT, Goudsmit J. Wolfs TF, et al. AIDS Res Hum Retroviruses. 1989 Oct;5(5):535-40. doi: 10.1089/aid.1989.5.535. AIDS Res Hum Retroviruses. 1989. PMID: 2480153

7

Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis.

Zwart G, Wolfs TF, Bookelman R, Hartman S, Bakker M, Boucher CA, Kuiken C, Goudsmit J. Zwart G, et al. Among authors: wolfs tf. AIDS. 1993 Apr;7(4):467-74. doi: 10.1097/00002030-199304000-00003. AIDS. 1993. PMID: 8507412

8

Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.

Wolfs TF, de Jong JJ, Van den Berg H, Tijnagel JM, Krone WJ, Goudsmit J. Wolfs TF, et al. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9938-42. doi: 10.1073/pnas.87.24.9938. Proc Natl Acad Sci U S A. 1990. PMID: 1702224 Free PMC article.

9

Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage.

Boucher CA, de Jager MH, Debouck C, Epstein LG, de Wolf F, Wolfs TF, Goudsmit J. Boucher CA, et al. Among authors: wolfs tf. J Clin Microbiol. 1989 Jul;27(7):1577-81. doi: 10.1128/jcm.27.7.1577-1581.1989. J Clin Microbiol. 1989. PMID: 2671017 Free PMC article.

10

HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.

Wolfs TF, Breederveld C, Krone WJ, vd Hoek L, Bakker M, Smit L, Goudsmit J. Wolfs TF, et al. Thromb Haemost. 1988 Jun 16;59(3):396-9. Thromb Haemost. 1988. PMID: 3142077 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters